Exercise in Patients With Metabolic Dysfunction-Associated Steatohepatitis.
作者信息
Stine Jonathan G
机构信息
Fatty Liver Program Director, Penn State Health Liver Center Director of Research, Penn State Health Associate Professor of Medicine and Public Health Sciences Division of Gastroenterology & Hepatology Department of Medicine Penn State Health Milton S. Hershey Medical Center Hershey, Pennsylvania.
出版信息
Gastroenterol Hepatol (N Y). 2025 Jun;21(6):390-393.
Abstract
摘要
相似文献
1
Exercise in Patients With Metabolic Dysfunction-Associated Steatohepatitis.代谢功能障碍相关脂肪性肝炎患者的运动
Gastroenterol Hepatol (N Y). 2025 Jun;21(6):390-393.
2
NASH-CHECK patient-reported outcome instrument: evaluation of content and face validity for patients with metabolic dysfunction-associated steatohepatitis and compensated cirrhosis.NASH-CHECK患者报告结局量表：对代谢功能障碍相关脂肪性肝炎和代偿期肝硬化患者的内容效度和表面效度评估
J Patient Rep Outcomes. 2025 Jul 1;9(1):76. doi: 10.1186/s41687-025-00881-6.
3
Effects of Mediterranean diet, exercise, and their combination on body composition and liver outcomes in metabolic dysfunction-associated steatotic liver disease: a systematic review and meta-analysis of randomized controlled trials.地中海饮食、运动及其联合干预对代谢功能障碍相关脂肪性肝病患者身体成分和肝脏结局的影响：一项随机对照试验的系统评价和荟萃分析
BMC Med. 2025 Aug 27;23(1):502. doi: 10.1186/s12916-025-04320-7.
4
Hepatocellular CMPK2 promotes the development of metabolic dysfunction-associated steatohepatitis.肝细胞CMPK2促进代谢功能障碍相关脂肪性肝炎的发展。
J Hepatol. 2025 Jan 22. doi: 10.1016/j.jhep.2025.01.008.
5
Phase 1 randomized double-blind study of an RNA interference therapeutic targeting HSD17B13 for metabolic dysfunction-associated steatohepatitis.一项针对代谢功能障碍相关脂肪性肝炎的靶向HSD17B13的RNA干扰疗法的1期随机双盲研究。
J Hepatol. 2025 Jun 26. doi: 10.1016/j.jhep.2025.05.031.
6
Cinnabarinic acid protects against metabolic dysfunction-associated steatohepatitis by activating aryl hydrocarbon receptor-dependent AMPK signaling.朱红酸通过激活芳烃受体依赖性AMPK信号通路预防代谢功能障碍相关脂肪性肝炎。
Am J Physiol Gastrointest Liver Physiol. 2025 Apr 1;328(4):G433-G447. doi: 10.1152/ajpgi.00337.2024. Epub 2025 Mar 10.
7
Inhibition of ATGL alleviates MASH via impaired PPARα signalling that favours hydrophilic bile acid composition in mice.抑制脂肪甘油三酯脂肪酶（ATGL）可通过损害过氧化物酶体增殖物激活受体α（PPARα）信号通路来减轻小鼠的巨噬细胞活化综合征（MASH），该信号通路有利于亲水性胆汁酸组成。
J Hepatol. 2025 Apr;82(4):658-675. doi: 10.1016/j.jhep.2024.09.037. Epub 2024 Sep 30.
8
Endoscopic Sleeve Gastroplasty Plus Lifestyle Intervention in Patients With Metabolic Dysfunction-associated Steatohepatitis: A Multicenter, Sham-controlled, Randomized Trial.内镜下袖状胃成形术联合生活方式干预治疗代谢功能障碍相关脂肪性肝炎患者：一项多中心、假手术对照、随机试验
Clin Gastroenterol Hepatol. 2025 Aug;23(9):1556-1566.e3. doi: 10.1016/j.cgh.2024.10.027. Epub 2024 Dec 16.
10
Resolution of Metabolic Dysfunction-associated Steatohepatitis With No Worsening of Fibrosis After Bariatric Surgery Improves 15-year Survival: A Prospective Cohort Study.减重手术后代谢功能障碍相关脂肪性肝炎的缓解且纤维化无恶化可改善15年生存率：一项前瞻性队列研究
Clin Gastroenterol Hepatol. 2024 Dec 19. doi: 10.1016/j.cgh.2024.10.025.
本文引用的文献
1
Aerobic exercise interventions lead to MASH resolution in clinical trials: Pooled analysis using the MASH resolution index.有氧运动干预在临床试验中可使MASH得到缓解：使用MASH缓解指数的汇总分析。
Hepatol Commun. 2025 Mar 24;9(4). doi: 10.1097/HC9.0000000000000681. eCollection 2025 Apr 1.
2
Histological improvements following energy restriction and exercise: The role of insulin resistance in resolution of MASH.能量限制和运动后的组织学改善：胰岛素抵抗在MASH消退中的作用。
J Hepatol. 2024 Nov;81(5):781-793. doi: 10.1016/j.jhep.2024.06.017. Epub 2024 Jun 22.
3
Exercise improves surrogate measures of liver histological response in metabolic dysfunction-associated steatotic liver disease.运动改善代谢功能障碍相关脂肪性肝病中肝组织学应答的替代指标。
Liver Int. 2024 Sep;44(9):2368-2381. doi: 10.1111/liv.15947. Epub 2024 Jun 7.
4
Exercise training improves serum biomarkers of liver fibroinflammation in patients with metabolic dysfunction-associated steatohepatitis.运动训练可改善代谢功能障碍相关脂肪性肝炎患者血清肝纤维化炎症生物标志物。
Liver Int. 2024 Feb;44(2):532-540. doi: 10.1111/liv.15769. Epub 2023 Nov 28.
5
Exercise in the Management of Metabolic-Associated Fatty Liver Disease (MAFLD) in Adults: A Position Statement from Exercise and Sport Science Australia.运动在代谢相关脂肪性肝病（MAFLD）成人管理中的作用：来自澳大利亚运动与运动科学学会的立场声明。
Sports Med. 2023 Dec;53(12):2347-2371. doi: 10.1007/s40279-023-01918-w. Epub 2023 Sep 11.
6
American College of Sports Medicine (ACSM) International Multidisciplinary Roundtable report on physical activity and nonalcoholic fatty liver disease.美国运动医学学会（ACSM）国际多学科圆桌会议关于体力活动与非酒精性脂肪性肝病的报告。
Hepatol Commun. 2023 Mar 30;7(4). doi: 10.1097/HC9.0000000000000108. eCollection 2023 Apr 1.
7
Mobile health lifestyle intervention program leads to clinically significant loss of body weight in patients with NASH.移动健康生活方式干预方案可使 NASH 患者的体重出现临床显著下降。
Hepatol Commun. 2023 Mar 17;7(4). doi: 10.1097/HC9.0000000000000052. eCollection 2023 Apr 1.
8
Exercise Training Is Associated With Treatment Response in Liver Fat Content by Magnetic Resonance Imaging Independent of Clinically Significant Body Weight Loss in Patients With Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis.运动训练与非酒精性脂肪性肝病患者的肝脏脂肪含量磁共振成像治疗反应相关，与临床显著体重减轻无关：系统评价和荟萃分析。
Am J Gastroenterol. 2023 Jul 1;118(7):1204-1213. doi: 10.14309/ajg.0000000000002098. Epub 2022 Dec 23.
9
Breaking Down Barriers to Physical Activity in Patients with Nonalcoholic Fatty Liver Disease.打破非酒精性脂肪性肝病患者身体活动障碍。
Dig Dis Sci. 2021 Oct;66(10):3604-3611. doi: 10.1007/s10620-020-06673-w. Epub 2020 Oct 23.
10
Zotero 插件